Q: I've been searching for relatively cheap canadian pharma stocks that have postive cashflow and earnings growth. I recently came across CRH Medical, a recent recommendation of J.Donville. After accounting for the recent aquisition (trailing earning, some dilution, and debt), to me, it still appears quite cheap relative to the sector. I realize there is some execution risk, and now a fair bit of debt, but it seems reasonable. How do you assess this company and compare it to other small/growthy names in the sector? I currently have a half position in CRH and I am thinking about doubling down. I also own PHM and CPH in the sector but they don't look as cheap anymore. Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Would you please give me a quick rating for the following companies: Concordia (CXR), DH Corp (DH), Boyd Fund (BYD.UN) and CGI Group (GIB.A) -- in the A, B, C rating that 5I does. I realize a full analysis is impossible, but just wondered in a "wish list" of descending companies, which would you choose for a post-Christmas present to yourself, for growth in 2015? Thanks.
Q: Hello Peter & Co,
Hope you had a Merry Christmas and wish you a Happy New Year.
12% of my portfolio is in Health/Pharma which comprises CCT, CPH, CXR, GUD, RX and XHC; is there a point to adding CRH which is similar to RX?
Thanks,
Tony
Hope you had a Merry Christmas and wish you a Happy New Year.
12% of my portfolio is in Health/Pharma which comprises CCT, CPH, CXR, GUD, RX and XHC; is there a point to adding CRH which is similar to RX?
Thanks,
Tony
Q: Can I get your views on this company at present stock price. Does not want to seem to pull back any. P/E seems high at 48x and P/B is at 18. Is this considered high for small cap?
thanks
thanks
Q: What do you think of their business model and what catalysts will affect the stock going forward? Do you see it doubling in 2015? Thank you.
Q: Hello Peter and team,
I am getting ready to make my 2015 TFSA contribution on Jan 2nd, and with some cash in that account I would like to invest in one or two growthy stocks. What are your top 5 suggestions for a TFSA at this time (holding period is 3 years minimum).
Also can you list your top 3 TFSA suggestions in the Information Technology and the Health Care sectors.
Please rank your choices highest to lowest.
Happy New Year,
Paul J.
I am getting ready to make my 2015 TFSA contribution on Jan 2nd, and with some cash in that account I would like to invest in one or two growthy stocks. What are your top 5 suggestions for a TFSA at this time (holding period is 3 years minimum).
Also can you list your top 3 TFSA suggestions in the Information Technology and the Health Care sectors.
Please rank your choices highest to lowest.
Happy New Year,
Paul J.
Q: Could you advise if Blackberry is a buy after this company reported their financial results today.
Thanks
Thanks
Q: I was disappointed to read this week that the “Growth Portfolio” won’t be available until March. I need to be very aggressive for a while. I currently hold: atd.b, ccl.b, stn, gil, aya, which I suspect will be candidates for this portfolio. Could you name a couple of others that you are considering. Thanks.
Q: Hello Peter
I would like to diversify into the health care and pharma industry. I could not find in the database any companies that have a minimum of a B rating. Are there any health care and pharma companies that you would recommend with at least a B rating. Would an ETF be better? I would like to hold it in my rsp and have a 3-5 yr time frame to hold.
Thank you
I would like to diversify into the health care and pharma industry. I could not find in the database any companies that have a minimum of a B rating. Are there any health care and pharma companies that you would recommend with at least a B rating. Would an ETF be better? I would like to hold it in my rsp and have a 3-5 yr time frame to hold.
Thank you
Q: I have accumulated Canadian biotech/pharma companies RX, CPH, CXR, MSL, NRI and NHC with a hope that some of them might be taken over by the others. Do you think there is a possibility of any of these companies buying the other. Who do you think will be the most probable target and who is the most likely acquirer. Thanks
Q: I see CXR is falling. Any news you can detect?
Q: Hi Peter,
Would you give me your opinion on above stock please. I consider to start buying some now.
Thank you.
Albert
Would you give me your opinion on above stock please. I consider to start buying some now.
Thank you.
Albert
Q: Some reasons for good equity market.Seasonality & 3rd year of mid term election indicate strong Nov to April period.Low interest rate.Increasing earnings growth. Please advise if it is time to invest now?.If so,please provide some appropriate "growth & dividend" stocks. Thanks a lot for your usual excellent advices & serices
Q: In spite of the much improved 2015 Q1 operating results over 2014 Q1, LMP's stock price had dropped from its highs in August/September by some 40% by early November (although it has a major rally over the last week or so but still down significantly from its highs). Your comments on this company going forward would be much appreciated.
H.S.
H.S.
Q: Is there news on PLI? It's hit a new year high.
Q: Hello Peter,
Is there additional information on PHM from your previous answer as the stock continues to move higher? Also, what is your sell strategy for small caps versus large caps? Do you sell to get back to your weighting (assume you had 3 percent) or let the winners run until the fundamentals are no longer in play? My main concern with the latter is if the fundamentals deteriorate, the stock may take a huge hit. Any comments please ?
Is there additional information on PHM from your previous answer as the stock continues to move higher? Also, what is your sell strategy for small caps versus large caps? Do you sell to get back to your weighting (assume you had 3 percent) or let the winners run until the fundamentals are no longer in play? My main concern with the latter is if the fundamentals deteriorate, the stock may take a huge hit. Any comments please ?
Q: CXR released its Q3 earnings last night. Diluted earnings per share were 0.35 versus an expected 0.58. Your comments on the report.
I was waiting for the earnings report before taking a half position in CXR. Should I buy now, or wait?
Paul J.
I was waiting for the earnings report before taking a half position in CXR. Should I buy now, or wait?
Paul J.
Q: Hi 5i: What is your assessment of Kelso's recent results, and what do you think of its prospects over the next year or two? Thanks again for your invaluable advice.
Q: I currently owned TRP but would like to sell and replace with a more growth stock. I also own Enbridge but have no intention of selling this one. What would you suggest?I am looking for at least 3-5 years hold.
Thanks
Thanks
Q: Hi Peter,
Can you give me your opinion on this company and would you consider it a buy? thanks Clare
Can you give me your opinion on this company and would you consider it a buy? thanks Clare